# A TEst and Treat Intervention aMong Current People Who Inject Drugs With HCV Attending Needle and Syringe PrOgrams

> **NCT03492112** · NA · COMPLETED · sponsor: **Kirby Institute** · enrollment: 101 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DEVICE:** HCV RNA Point of Care
- **DRUG:** Sofosbuvir/velpatasvir
- **DRUG:** Glecaprevir/pibrentasvir

## Key facts

- **NCT ID:** NCT03492112
- **Lead sponsor:** Kirby Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-10
- **Primary completion:** 2021-11-30
- **Final completion:** 2021-11-30
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2023-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03492112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03492112, "A TEst and Treat Intervention aMong Current People Who Inject Drugs With HCV Attending Needle and Syringe PrOgrams". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT03492112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*